l carnitine and cancer patients L-Carnitine Supplementation for the Management of Fatigue in With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Dysfunction of the carnitine cycle

Ecotoxicology 25:14171425

Our in vitro studies using cultured vascular SMC showed that the beneficial effects of DT-109 occur through multiple mechanisms, including the inhibition of inflammation, prevention of smooth muscle osteogenic phenotype switching, and reduction of oxidative stress

In 2005, a controlled trial (N = 22 LOE3b) of LC (50 mg/kg daily for 6 months) in children with RS showed a significant increase in heart rate variability, suggesting that LC supplementation may reduce the risk of sudden death in children with RS [86]

compound may cause staining if spilled Storage: Store at room temperature, away from direct light

On the classification of long non-coding RNAs